News and blogs
340 results found.
A Christmas message from Blood Cancer UK
Christmas always seems a natural point to look back and take stock of the year. I won't sugar coat the past 12 months, but we can all be proud of how our community has come together and what we've achieved.
Shielding at Christmas will be lonely... but I believe and hope in the future
Pat always hosts Christmas for the whole family. But with the vaccine in sight, she's made the decision to stay apart until the new year.
From coronavirus to clinic: how did we get a vaccine?
We know a lot of people with blood cancer have questions on whether the coronavirus vaccine is safe after such a short amount of time. We hope to answer some of these questions by explaining how these vaccines have been developed.
My shining light, Aly
This Christmas, Jo introduced us to a very special nurse, Aly, who was one of the shining lights that helped her throughout her treatment. Whether it was to make her laugh, give a warm hug, or the confidence to keep going.
Coronavirus vaccine approved for use next week: Our response
Gemma Peters, Chief Executive of Blood Cancer UK, responds to the news that the Pfizer/BioNTech coronavirus vaccine is approved for use and will be deployed as early as next week.
Giving back to the community
A year ago, Sunny was in a critical condition. With a positive frame of mind to help him recover, he's been using his new lease of and genuine appreciation of life to help vulnerable people in the community throughout the pandemic.
Making decisions about your Christmas plans if you have blood cancer
If you’re finding it hard to plan or think about Christmas this year, here are some things that might help you with decision-making and techniques for coping with uncertainty.
The coronavirus vaccine: what you need to know
We explain what we know about the potential vaccines and what they could mean for people with blood cancer.
A list of employers paying fully salary to vulnerable staff who can’t work from home during lockdown
About 1 million working age people in England are “clinically extremely vulnerable” to the coronavirus.
How does the coronavirus affect people with blood cancer?
We're funding vital research that will explore how different types of blood cancer might affect someone’s individual level of risk from coronavirus. This could lead to tailored advice for people with blood cancer during this pandemic.
Let the next chapter bring new adventures
Franko tells us about his journey with multiple myeloma, from his diagnosis through to remission, and what has helped him along the way. During lockdown, he became a volunteer on our forum, using his experiences to help others.
Our response to the latest shielding guidance in England
The Government announced that England will enter a second lockdown from 5 November, and have advised clinically extremely vulnerable people not to go out to work if they can't work from home. Here is our response.
Our response to the latest coronavirus advice
On Saturday 31 October 2020, the Government announced their plans for four weeks of national restrictions in England and gave new advice for those who are shielding. Here is our response.
The pool of uncertainty
Angie explains her mounting worries and anxieties about the impact of coronavirus. Like many people with blood cancer, she feels forced to neglect her health to earn money, and return to a workplace where she doesn't feel safe.
What does the three-tier system mean for people shielding in England?
We outline what the current Government advice and recommendations are for people with blood cancer in each alert level under the new three-tier system.
Does having chronic lymphocytic leukaemia (CLL) increase your risk from the coronavirus?
We take a closer look at the findings of two studies into people with CLL who have had the coronavirus.
We call for the Government to urgently revise new shielding guidance
Following the Government's announcement on shielding, our Chief Executive Gemma Peters is calling on the Government to urgently revise the new shielding guidance and give people with blood cancer financial and mental health support.
Because my journey can help someone with theirs
It's been four and a half years since Jane achieved remission. Here, she reflects on the painful symptoms and "horrible" side effects of her blood cancer treatment, and explains that without taking part in a clinical trial, she wouldn't be here today.
Because research can beat blood cancer in a generation
Together we’ve achieved a lot in the last 60 years. We've invested over £500million in research and improved diagnosis and treatments for people with blood cancer. But can we beat blood cancer in the next generation? Yes, and here's how...
My only option was all that I needed
Johanna was told that she had only one treatment option available to her – to take part in our clinical trial. Thanks to this, Johanna was able to control her leukaemia and spend more valuable time with her family.
